6711000001103: Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Orphenadrine\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Orphenadrine\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\UK product\Trade family\Biorphen\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist\Product containing orphenadrine\Orphenadrine\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist\Product containing orphenadrine\Orphenadrine\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist\Product containing orphenadrine\Product containing orphenadrine in oral dose form (medicinal product form)\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing orphenadrine\Orphenadrine\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing orphenadrine\Orphenadrine\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing orphenadrine\Product containing orphenadrine in oral dose form (medicinal product form)\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing orphenadrine\Orphenadrine\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing orphenadrine\Orphenadrine\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing orphenadrine\Product containing orphenadrine in oral dose form (medicinal product form)\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Orphenadrine\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Orphenadrine\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing orphenadrine in oral dose form (medicinal product form)\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing orphenadrine\Orphenadrine\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing orphenadrine\Orphenadrine\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing orphenadrine\Product containing orphenadrine in oral dose form (medicinal product form)\Product containing only orphenadrine in oral dose form (medicinal product form)\Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution\Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17130301000001116 Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

66613001000001111 Biorphen 25mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Is a	Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has active ingredient	Orphenadrine hydrochloride	false	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral solution	false	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Is a	Biorphen	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has specific active ingredient	Orphenadrine hydrochloride	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Has manufactured dose form	Oral liquid	false	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd) 200 ml	Is pack of	False	Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd) 200 ml	Has AMP	True	Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17130301000001116	Biorphen 25mg/5ml oral solution (Alliance Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
66613001000001111	Biorphen 25mg/5ml oral solution (Rosemont Pharmaceuticals Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module